AMICAS To Go Private in $217 Million Buyout
Medical imaging vendor AMICAS announced this morning that it will be bought by private equity firm Thoma Bravo LLC for $5.35 per share, a 21% premium to Thursday’s closing price.
Stephen Kahane, AMICAS president, CEO, and chairman, was quoted as saying, “With the additional capital and operational expertise available to AMICAS through Thoma Bravo, we will be able to grow as the needs of our customers evolve and will be enabled to better serve our market.”
With McGraw’s new position at Transcarent, it seems like Glen Tullman might be getting the Allscripts band back together.